Cargando…
Real-world treatment attrition rates in advanced esophagogastric cancer
BACKGROUND: Over the last decade, multiple agents have demonstrated efficacy for advanced esophagogastric cancer (EGC). Despite the availability of later lines of therapy, there remains limited real-world data about the treatment attrition rates between lines of therapy. AIM: To characterize the use...
Autores principales: | Tsang, Erica S, Lim, Howard J, Renouf, Daniel J, Davies, Janine M, Loree, Jonathan M, Gill, Sharlene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584053/ https://www.ncbi.nlm.nih.gov/pubmed/33132652 http://dx.doi.org/10.3748/wjg.v26.i39.6027 |
Ejemplares similares
-
Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
por: Tsang, Erica S., et al.
Publicado: (2020) -
Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function
por: Zheng, Guo-Liang, et al.
Publicado: (2021) -
Thoracoscopic esophagectomy is related to better outcomes in early adenocarcinoma of esophagogastric junction tumors
por: Takeda, Flavio Roberto, et al.
Publicado: (2021) -
Surgical resection of gastric stump cancer following proximal gastrectomy for adenocarcinoma of the esophagogastric junction
por: Ma, Fu-Hai, et al.
Publicado: (2019) -
Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer
por: Takeuchi, Masashi, et al.
Publicado: (2022)